Literature DB >> 24225667

A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds.

Benoît Bertrand1, Angela Casini.   

Abstract

From wedding rings on fingers to stained glass windows, by way of Olympic medals, gold has been highly prized for millennia. Nowadays, organometallic gold compounds occupy an important place in the field of medicinal inorganic chemistry due to their unique chemical properties with respect to gold coordination compounds. In fact, several studies have proved that they can be used to develop highly efficient n class="Chemical">metal-based drugs with possible applications in the treatment of cancer. This Perspective summarizes the results obtained for different families of bioactive organometallic gold compounds including cyclometallated gold(iii) complexes with C,N-donor ligands, gold(I) and gold(I/III) N-heterocyclic (NHC) carbene complexes, as well as gold(I) alkynyl complexes, with promising anticancer effects. Most importantly, we will focus on recent developments in the field and discuss the potential of this class of organometallic compounds in relation to their versatile chemistry and innovative mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24225667     DOI: 10.1039/c3dt52524d

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  46 in total

1.  Preparation of Titanocene-Gold Compounds Based on Highly Active Gold(I)-N-Heterocyclic Carbene Anticancer Agents: Preliminary in vitro Studies in Renal and Prostate Cancer Cell Lines.

Authors:  Natalia Curado; Nora Giménez; Kirill Miachin; Mélanie Aliaga-Lavrijsen; Mike A Cornejo; Andrzej A Jarzecki; María Contel
Journal:  ChemMedChem       Date:  2019-04-12       Impact factor: 3.466

2.  Design, synthesis and characterisation of new chimeric ruthenium(II)-gold(I) complexes as improved cytotoxic agents.

Authors:  Lara Massai; Jacob Fernández-Gallardo; Annalisa Guerri; Annarosa Arcangeli; Serena Pillozzi; María Contel; Luigi Messori
Journal:  Dalton Trans       Date:  2015-05-21       Impact factor: 4.390

3.  Protein Recognition of Gold-Based Drugs: 3D Structure of the Complex Formed When Lysozyme Reacts with Aubipy(c.).

Authors:  Luigi Messori; Maria Agostina Cinellu; Antonello Merlino
Journal:  ACS Med Chem Lett       Date:  2014-07-31       Impact factor: 4.345

4.  Ex vivo toxicological evaluation of experimental anticancer gold(i) complexes with lansoprazole-type ligands.

Authors:  Natalia Estrada-Ortiz; Elena Lopez-Gonzales; Ben Woods; Stefan Stürup; Inge A M de Graaf; Geny M M Groothuis; Angela Casini
Journal:  Toxicol Res (Camb)       Date:  2019-09-20       Impact factor: 3.524

5.  Gold(I) NHC-based homo- and heterobimetallic complexes: synthesis, characterization and evaluation as potential anticancer agents.

Authors:  Benoît Bertrand; Anna Citta; Inge L Franken; Michel Picquet; Alessandra Folda; Valeria Scalcon; Maria Pia Rigobello; Pierre Le Gendre; Angela Casini; Ewen Bodio
Journal:  J Biol Inorg Chem       Date:  2015-07-23       Impact factor: 3.358

6.  Versatile synthesis of cationic N-heterocyclic carbene-gold(i) complexes containing a second ancillary ligand. Design of heterobimetallic ruthenium-gold anticancer agents.

Authors:  Jacob Fernández-Gallardo; Benelita T Elie; Mercedes Sanaú; María Contel
Journal:  Chem Commun (Camb)       Date:  2016-02-21       Impact factor: 6.222

Review 7.  Aquaporins: important but elusive drug targets.

Authors:  Alan S Verkman; Marc O Anderson; Marios C Papadopoulos
Journal:  Nat Rev Drug Discov       Date:  2014-03-14       Impact factor: 84.694

8.  Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes.

Authors:  C Ceresa; G Nicolini; S Semperboni; V Gandin; M Monfrini; F Avezza; P Alberti; A Bravin; M Pellei; C Santini; Guido Cavaletti
Journal:  Neurotox Res       Date:  2018-01-17       Impact factor: 3.911

9.  Biscarbene gold(i) complexes: structure-activity-relationships regarding antibacterial effects, cytotoxicity, TrxR inhibition and cellular bioavailability.

Authors:  Claudia Schmidt; Bianka Karge; Rainer Misgeld; Aram Prokop; Mark Brönstrup; Ingo Ott
Journal:  Medchemcomm       Date:  2017-06-27       Impact factor: 3.597

10.  Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancer.

Authors:  Benelita T Elie; Jacob Fernández-Gallardo; Natalia Curado; Mike A Cornejo; Joe W Ramos; María Contel
Journal:  Eur J Med Chem       Date:  2018-10-17       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.